Picture of Valbiotis SA logo

ALVAL — Valbiotis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Valbiotis Presents Additional Positive Results From Heart Clinical Study On Totum•070

Oct 3 (Reuters) - Valbiotis SA  ALVAL.PA :
    * VALBIOTIS PRESENTS ADDITIONAL POSITIVE RESULTS FROM THE
HEART
CLINICAL STUDY ON TOTUM•070 FOR HYPERCHOLESTEROLEMIA
    * COMPANY CONFIRMS ITS OBJECTIVE OF MARKETING PRODUCT BY
FIRST
HALF OF 2024 AT LATEST AND IS INTENSIFYING ITS DISCUSSIONS WITH
MAJOR PLAYERS IN HEALTH AND NUTRITION SECTORS

Source text for Eikon:  ID:nBw8XJsc1a 
Further company coverage:  ALVAL.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Valbiotis SA

See all news